1.9 USD
-0.08 (-4.04%)
SURG gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 22 industry peers in the Wireless Telecommunication Services industry. Both the profitability and financial health of SURG have multiple concerns. SURG has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
SURG had negative earnings in the past year.
In the past year SURG has reported a negative cash flow from operations.
In the past 5 years SURG reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: SURG reported negative operating cash flow in multiple years.
1.2 Ratios
SURG has a worse Return On Assets (-320.77%) than 95.45% of its industry peers.
SURG has a worse Return On Equity (-42037.73%) than 90.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -320.77% | ||
| ROE | -42037.73% | ||
| ROIC | N/A |
ROA(3y)-47.87%
ROA(5y)-71.76%
ROE(3y)-79.87%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for SURG so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SURG does not have a ROIC to compare to the WACC, probably because it is not profitable.
SURG has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SURG has more shares outstanding
Compared to 1 year ago, SURG has a worse debt to assets ratio.
2.2 Solvency
SURG has an Altman-Z score of -13.10. This is a bad value and indicates that SURG is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -13.10, SURG is not doing good in the industry: 95.45% of the companies in the same industry are doing better.
SURG has a Debt/Equity ratio of 53.87. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 53.87, SURG is doing worse than 90.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 53.87 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -13.1 |
ROIC/WACCN/A
WACC8.61%
2.3 Liquidity
A Current Ratio of 1.11 indicates that SURG should not have too much problems paying its short term obligations.
SURG's Current ratio of 1.11 is fine compared to the rest of the industry. SURG outperforms 68.18% of its industry peers.
A Quick Ratio of 0.84 indicates that SURG may have some problems paying its short term obligations.
SURG has a Quick ratio (0.84) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
SURG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -87.61%.
The Revenue for SURG has decreased by -55.61% in the past year. This is quite bad
The Revenue has been growing by 18.83% on average over the past years. This is quite good.
EPS 1Y (TTM)-87.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.32%
Revenue 1Y (TTM)-55.61%
Revenue growth 3Y6.01%
Revenue growth 5Y18.83%
Sales Q2Q%291.64%
3.2 Future
Based on estimates for the next years, SURG will show a very strong growth in Earnings Per Share. The EPS will grow by 44.47% on average per year.
The Revenue is expected to grow by 63.43% on average over the next years. This is a very strong growth
EPS Next Y65.13%
EPS Next 2Y44.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.56%
Revenue Next 2Y63.43%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
SURG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 9.31, which indicates a very decent valuation of SURG.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SURG indicates a rather cheap valuation: SURG is cheaper than 86.36% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.21, SURG is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 9.31 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
SURG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SURG's earnings are expected to grow with 44.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.47%
EPS Next 3YN/A
5. Dividend
5.1 Amount
SURG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:SURG (12/1/2025, 8:00:00 PM)
1.9
-0.08 (-4.04%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)
Earnings (Next)
Inst Owners8.12%
Inst Owner Change12.95%
Ins Owners36.83%
Ins Owner Change-0.77%
Market Cap39.98M
Revenue(TTM)60.88M
Net Income(TTM)-48.81M
Analysts80
Price Target9.69 (410%)
Short Float %1.7%
Short Ratio2.06
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-68.1%
Min EPS beat(2)-75.97%
Max EPS beat(2)-60.24%
EPS beat(4)0
Avg EPS beat(4)-152.16%
Min EPS beat(4)-304.04%
Max EPS beat(4)-60.24%
EPS beat(8)1
Avg EPS beat(8)-184.11%
EPS beat(12)4
Avg EPS beat(12)-2.85%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-22.44%
Min Revenue beat(2)-30.02%
Max Revenue beat(2)-14.86%
Revenue beat(4)1
Avg Revenue beat(4)-19.09%
Min Revenue beat(4)-45.89%
Max Revenue beat(4)14.43%
Revenue beat(8)2
Avg Revenue beat(8)-11.04%
Revenue beat(12)3
Avg Revenue beat(12)-9.16%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.56%
PT rev (3m)5.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)34.09%
EPS NY rev (1m)0%
EPS NY rev (3m)3.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-26.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-18.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 9.31 | ||
| P/S | 1.1 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 344.32 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.12
EYN/A
EPS(NY)0.2
Fwd EY10.74%
FCF(TTM)-1.66
FCFYN/A
OCF(TTM)-1.63
OCFYN/A
SpS1.73
BVpS0.01
TBVpS-0.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -320.77% | ||
| ROE | -42037.73% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-47.87%
ROA(5y)-71.76%
ROE(3y)-79.87%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover2.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 53.87 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | -13.1 |
F-Score2
WACC8.61%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-87.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.32%
EPS Next Y65.13%
EPS Next 2Y44.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-55.61%
Revenue growth 3Y6.01%
Revenue growth 5Y18.83%
Sales Q2Q%291.64%
Revenue Next Year20.56%
Revenue Next 2Y63.43%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3934%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year48.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-937.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-924.59%
OCF growth 3YN/A
OCF growth 5YN/A
SURGEPAYS INC / SURG FAQ
Can you provide the ChartMill fundamental rating for SURGEPAYS INC?
ChartMill assigns a fundamental rating of 2 / 10 to SURG.
What is the valuation status of SURGEPAYS INC (SURG) stock?
ChartMill assigns a valuation rating of 4 / 10 to SURGEPAYS INC (SURG). This can be considered as Fairly Valued.
What is the profitability of SURG stock?
SURGEPAYS INC (SURG) has a profitability rating of 0 / 10.
Can you provide the expected EPS growth for SURG stock?
The Earnings per Share (EPS) of SURGEPAYS INC (SURG) is expected to grow by 65.13% in the next year.